Benton Susan
SEC CIK 1373649 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Dir | 243.9K | $91.4K | — | 13 | 2021-07-01 | 2026-04-20 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
| 11 | Benton Susan | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 16:30 | 2026-04-20 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | $0.00 | +24.4K | 243.9K | +11% | $0 | |
| D | 2025-05-02 | 2025-04-30 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | $0.00 | +79.5K | 219.5K | +57% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | $0.00 | +41.1K | 140.0K | +42% | $0 |
| 2024-01-03 | 2024-01-01 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +19.4K | 98.9K | +24% | — | |
| D | 2023-06-08 | 2023-06-06 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | $0.00 | +11.0K | 79.5K | +16% | $0 |
| 2023-04-21 | 2023-04-19 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +1,053 | 68.5K | +2% | — | |
| 2023-01-12 | 2023-01-11 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +16.3K | 67.4K | +32% | — | |
| M | 2022-07-06 | 2022-07-01 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +18.7K | 51.2K | +58% | — |
| 2022-04-05 | 2022-04-01 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +3,395 | 32.5K | +12% | — | |
| 2022-01-05 | 2022-01-03 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +2,949 | 29.1K | +11% | — | |
| 2021-10-04 | 2021-10-01 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +2,135 | 26.1K | +9% | — | |
| 2021-09-03 | 2021-09-02 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | P - Purchase | $4.57 | +20.0K | 24.0K | +503% | +$91.4K | |
| 2021-07-02 | 2021-07-01 | IRD | Opus Genetics, Inc. | Benton Susan | Dir | A - Grant | — | +2,083 | 3,976 | +110% | — |
Purchase Sale Sale after option exercise All abbreviations